Collector
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug | Collector
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
MarketWatch

Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug

Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.

Go to News Site